How much profit has Camurus made this year?
Camurus has made 367.57 M SEK this year.
Camurus Net Income 2024
Camurus Net Income
367.57 M SEK
Ticker
CAMX.ST
ISIN
SE0007692850
WKN
A2ABG7
In 2024, Camurus's profit amounted to 367.57 M SEK, a -14.8% increase from the 431.44 M SEK profit recorded in the previous year.
The Camurus Net Income history
| YEAR | NET INCOME (undefined SEK) |
|---|---|
| 2029e | - |
| 2028e | 2.78 |
| 2027e | 1.91 |
| 2026e | 1.93 |
| 2025e | 1.14 |
| 2024e | 0.37 |
| 2023 | 0.43 |
| 2022 | 0.06 |
| 2021 | -0.09 |
| 2020 | -0.17 |
| 2019 | -0.29 |
| 2018 | -0.23 |
| 2017 | -0.19 |
| 2016 | -0.08 |
| 2015 | -0.16 |
| 2014 | 0.05 |
Camurus Revenue, EBIT, Net Income SE0007692850 · A2ABG7
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Camurus, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Camurus from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Camurus’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Camurus. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Camurus’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Camurus’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Camurus’s growth potential.
Camurus Revenue, EBIT and net profit per share
| Date | Camurus Revenue | Camurus EBIT | Camurus Net Income |
|---|---|---|---|
| 2029e | 9.44 B undefined | 0 undefined | 0 undefined |
| 2028e | 7.32 B undefined | 0 undefined | 2.78 B undefined |
| 2027e | 5.03 B undefined | 2.28 B undefined | 1.91 B undefined |
| 2026e | 4.53 B undefined | 2.33 B undefined | 1.93 B undefined |
| 2025e | 3.24 B undefined | 1.39 B undefined | 1.14 B undefined |
| 2024e | 1.97 B undefined | 438.64 M undefined | 367.57 M undefined |
| 2023 | 1.72 B undefined | 533.41 M undefined | 431.44 M undefined |
| 2022 | 956.34 M undefined | 65 M undefined | 55.55 M undefined |
| 2021 | 600.57 M undefined | -112.36 M undefined | -90.45 M undefined |
| 2020 | 336 M undefined | -206.57 M undefined | -167.27 M undefined |
| 2019 | 105.61 M undefined | -360.09 M undefined | -289.87 M undefined |
| 2018 | 49.32 M undefined | -287.78 M undefined | -234.68 M undefined |
| 2017 | 54.31 M undefined | -243.52 M undefined | -190.57 M undefined |
| 2016 | 113.74 M undefined | -103.14 M undefined | -80.99 M undefined |
| 2015 | 154.8 M undefined | -29.81 M undefined | -159.54 M undefined |
| 2014 | 208.21 M undefined | 62.32 M undefined | 48.35 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2014 | 208.21 M SEK | 62.32 M SEK | 48.35 M SEK |
| 2015 | 154.8 M SEK | -29.81 M SEK | -159.54 M SEK |
| 2016 | 113.74 M SEK | -103.14 M SEK | -80.99 M SEK |
| 2017 | 54.31 M SEK | -243.52 M SEK | -190.57 M SEK |
| 2018 | 49.32 M SEK | -287.78 M SEK | -234.68 M SEK |
| 2019 | 105.61 M SEK | -360.09 M SEK | -289.87 M SEK |
| 2020 | 336 M SEK | -206.57 M SEK | -167.27 M SEK |
| 2021 | 600.57 M SEK | -112.36 M SEK | -90.45 M SEK |
| 2022 | 956.34 M SEK | 65 M SEK | 55.55 M SEK |
| 2023 | 1.72 B SEK | 533.41 M SEK | 431.44 M SEK |
| 2024e | 1.97 B SEK | 438.64 M SEK | 367.57 M SEK |
| 2025e | 3.24 B SEK | 1.39 B SEK | 1.14 B SEK |
| 2026e | 4.53 B SEK | 2.33 B SEK | 1.93 B SEK |
| 2027e | 5.03 B SEK | 2.28 B SEK | 1.91 B SEK |
| 2028e | 7.32 B SEK | 0 SEK | 2.78 B SEK |
| 2029e | 9.44 B SEK | 0 SEK | 0 SEK |
Camurus stock margins SE0007692850 · A2ABG7
The Camurus margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Camurus. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Camurus.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Camurus's sales revenue. A higher gross margin percentage indicates that the Camurus retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Camurus's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Camurus's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Camurus's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Camurus. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Camurus's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Camurus Margin History
| Camurus Gross margin | Camurus Profit margin | Camurus EBIT margin | Camurus Profit margin |
|---|---|---|---|
| 2029e | 92.87 % | 0 % | 0 % |
| 2028e | 92.87 % | 0 % | 38.01 % |
| 2027e | 92.87 % | 45.32 % | 38.01 % |
| 2026e | 92.87 % | 51.44 % | 42.53 % |
| 2025e | 92.87 % | 42.88 % | 35.23 % |
| 2024e | 92.87 % | 22.25 % | 18.65 % |
| 2023 | 92.87 % | 31.07 % | 25.13 % |
| 2022 | 89.2 % | 6.8 % | 5.81 % |
| 2021 | 85.79 % | -18.71 % | -15.06 % |
| 2020 | 89.5 % | -61.48 % | -49.78 % |
| 2019 | 77.95 % | -340.98 % | -274.48 % |
| 2018 | 86.17 % | -583.48 % | -475.81 % |
| 2017 | 97.5 % | -448.41 % | -350.91 % |
| 2016 | 98.12 % | -90.68 % | -71.21 % |
| 2015 | 99.85 % | -19.25 % | -103.06 % |
| 2014 | 99.68 % | 29.93 % | 23.22 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2014 | 99.68 % | 29.93 % | 23.22 % |
| 2015 | 99.85 % | -19.25 % | -103.06 % |
| 2016 | 98.12 % | -90.68 % | -71.21 % |
| 2017 | 97.5 % | -448.41 % | -350.91 % |
| 2018 | 86.17 % | -583.48 % | -475.81 % |
| 2019 | 77.95 % | -340.98 % | -274.48 % |
| 2020 | 89.5 % | -61.48 % | -49.78 % |
| 2021 | 85.79 % | -18.71 % | -15.06 % |
| 2022 | 89.2 % | 6.8 % | 5.81 % |
| 2023 | 92.87 % | 31.07 % | 25.13 % |
| 2024e | 92.87 % | 22.25 % | 18.65 % |
| 2025e | 92.87 % | 42.88 % | 35.23 % |
| 2026e | 92.87 % | 51.44 % | 42.53 % |
| 2027e | 92.87 % | 45.32 % | 38.01 % |
| 2028e | 92.87 % | 0 % | 38.01 % |
| 2029e | 92.87 % | 0 % | 0 % |
Camurus Aktienanalyse
What does Camurus do?
Camurus AB is a Swedish biopharmaceutical company that specializes in the development of innovative medications for the treatment of serious diseases. The company was founded in 1991 by an interdisciplinary team of chemists, biologists, and drug developers and is headquartered in Lund, Sweden. Camurus AB specializes in the development of medications based on long-acting drug release technology. This technology allows medications to be administered in a very precise manner and over a longer period of time. This enables the benefits of a constant drug concentration in the blood to be utilized without requiring multiple doses per day. The core business of Camurus AB includes the development of medications for the treatment of pain, cancer, and addiction. The company works closely with clients, partners, and academic institutions to bring innovative medications to market that can have a significant impact on patients' lives. One of Camurus AB's key areas is pain therapy. The company has developed a novel technology that allows pain medications to be administered in the form of sprays and patches. This technology is based on the release of buprenorphine, a potent painkiller that previously could only be administered as repeated single doses or in the form of an implant due to its short half-life. The extended release allows for a sustained high concentration of the drug in the blood, without the need for the patient to take multiple single doses. Camurus AB is also active in oncology and has developed medications for the treatment of breast and prostate cancer that also utilize long-acting drug release. These medications help patients better tolerate the side effects of chemotherapy and improve their quality of life. Another important area for Camurus AB is addiction therapy. The company has developed a medication based on buprenorphine for the treatment of opioid dependence. This medication activates the body's own opioid receptors and reduces the cravings for further drugs. In recent years, Camurus AB has introduced several important products to the market and holds a wide portfolio of patents and protective rights. The company is committed to improving patient care and making global healthcare a better and more effective system. In conclusion, Camurus AB is an innovative biopharmaceutical company specializing in the development of medications for the treatment of pain, cancer, and addiction. The company is dedicated to improving global healthcare and works closely with clients, partners, and academic institutions to develop innovative, effective, and patient-oriented solutions. Camurus ist eines der beliebtesten Unternehmen auf Eulerpool.com.Net Income Details
Understanding Camurus's Profit Margins
The profit margins of Camurus represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Camurus's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.
Year-to-Year Comparison
Evaluating Camurus's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.
Impact on Investments
Camurus's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.
Interpreting Profit Fluctuations
When Camurus’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.
Frequently Asked Questions about Camurus stock
How has the profit developed compared to last year?
The profit has increased by -14.8% compared to last year fallen
What impact do the earnings have on the shareholders?
An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.
How does Camurus publish its earnings?
Camurus publishes its earnings in the form of quarterly or annual reports.
Which financial indicators are included in the quarterly or annual reports?
The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.
Why is it important for investors to know the earnings of Camurus?
The profits of Camurus are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.
How can one learn more about the earnings of Camurus?
You can learn more about the earnings of Camurus by reviewing the quarterly or annual reports or following the company presentations.
How much dividend does Camurus pay?
Over the past 12 months, Camurus paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Camurus is expected to pay a dividend of 0 SEK.
What is the dividend yield of Camurus?
The current dividend yield of Camurus is .
When does Camurus pay dividends?
Camurus pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Camurus?
Camurus paid dividends every year for the past 0 years.
What is the dividend of Camurus?
For the upcoming 12 months, dividends amounting to 0 SEK are expected. This corresponds to a dividend yield of 0 %.
In which sector is Camurus located?
Camurus is assigned to the 'Health' sector.
Wann musste ich die Aktien von Camurus kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Camurus from 10/4/2024 amounting to 0 SEK, you needed to have the stock in your portfolio before the ex-date on 10/4/2024.
When did Camurus pay the last dividend?
The last dividend was paid out on 10/4/2024.
What was the dividend of Camurus in the year 2023?
In the year 2023, Camurus distributed 0 SEK as dividends.
In which currency does Camurus pay out the dividend?
The dividends of Camurus are distributed in SEK.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Camurus
Our stock analysis for Camurus Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Camurus Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
